Apoptosis
Research Areas
Products Related to Apoptosis(675)
- GC50009LY 294002 hydrochlorideCAS: 934389-88-5Purity: >98.00%
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
- GC50190Fenretinide - d4CAS: 2118244-64-5Purity: >98%
Fenretinide - d4 is the deuterium labeled Fenretinide.
- GC50403KYP 2047CAS: 796874-99-2Purity: >99.00%
KYP 2047 is a potent, blood-brain barrier permeable prolyl oligopeptidase (POP; K i =0.023nM) inhibitor. By highly selectively inhibiting POP enzyme activity, KYP 2047 can modulate levels of neuropeptides in the brain that are associated with learning, memory, and neurodegenerative diseases.
- GC52104Ponatinib (hydrochloride)CAS: 1114544-31-8Purity: >98.00%
Ponatinib (hydrochloride) is a multi-target tyrosine kinase inhibitor that inhibits the activity of Abl (IC₅₀=0.37nM), PDGFRα (IC₅₀=1.1nM), VEGFR2 (IC₅₀=1.5nM), FGFR1 (IC₅₀=2.2nM), and Src (IC₅₀=5.4nM).
- GC52192(S)-4'-nitro-BlebbistatinCAS: 1621326-32-6Purity: >99.50%
(S)-4'-nitro-Blebbistatin is a non-cytotoxic, photostable, fluorescent and specific Myosin II inhibitor, usd in the study of the specific role of myosin II in physiological, developmental, and cell biological studies.
- GC52196RGD PeptideCAS: 114681-65-1Purity: >98.00%
RGD Peptide acts as an inhibitor of integrin-ligand interactions and plays an important role in cell adhesion, migration, growth, and differentiation.
- GC522275-(3',4'-Dihydroxyphenyl)-γ-ValerolactoneCAS: 21618-92-8Purity: >95.00%
An active metabolite of various polyphenols
- GC52269Cinnabarinic Acid-d4Purity: >99.00%
An internal standard for the quantification of cinnabarinic acid
- GC52288Fumonisin B1-13C34CAS: 1217458-62-2Purity: >95.00%
An internal standard for the quantification of fumonisin B 1
- GC52318Oleic Acid-13C5CAS: 1255644-48-4Purity: >95.00%
An internal standard for the quantification of oleic acid
- GC52367Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin PeptidePurity: >99.00%
A biotinylated and citrullinated mutant vimentin peptide
- GC52370Citrullinated Vimentin (R144) (139-159)-biotin PeptidePurity: >98.00%
A biotinylated and citrullinated vimentin peptide
- GC52371Vimentin (G146R) (139-159)-biotin PeptidePurity: >98.00%
A biotinylated mutant vimentin peptide
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC50009 | LY 294002 hydrochloride | 934389-88-5 | >98.00% | |
Prototypical PI 3-kinase inhibitor; also inhibits other kinases | ||||
| GC50190 | Fenretinide - d4 | 2118244-64-5 | >98% | |
Fenretinide - d4 is the deuterium labeled Fenretinide. | ||||
| GC50403 | KYP 2047 | 796874-99-2 | >99.00% | |
KYP 2047 is a potent, blood-brain barrier permeable prolyl oligopeptidase (POP; K i =0.023nM) inhibitor. By highly selectively inhibiting POP enzyme activity, KYP 2047 can modulate levels of neuropeptides in the brain that are associated with learning, memory, and neurodegenerative diseases. | ||||
| GC52104 | Ponatinib (hydrochloride) | 1114544-31-8 | >98.00% | |
Ponatinib (hydrochloride) is a multi-target tyrosine kinase inhibitor that inhibits the activity of Abl (IC₅₀=0.37nM), PDGFRα (IC₅₀=1.1nM), VEGFR2 (IC₅₀=1.5nM), FGFR1 (IC₅₀=2.2nM), and Src (IC₅₀=5.4nM). | ||||
| GC52115 | S-99 | 1124381-69-6 | >98.00% | |
An inhibitor of ASK1 | ||||
| GC52192 | (S)-4'-nitro-Blebbistatin | 1621326-32-6 | >99.50% | |
(S)-4'-nitro-Blebbistatin is a non-cytotoxic, photostable, fluorescent and specific Myosin II inhibitor, usd in the study of the specific role of myosin II in physiological, developmental, and cell biological studies. | ||||
| GC52196 | RGD Peptide | 114681-65-1 | >98.00% | |
RGD Peptide acts as an inhibitor of integrin-ligand interactions and plays an important role in cell adhesion, migration, growth, and differentiation. | ||||
| GC52227 | 5-(3',4'-Dihydroxyphenyl)-γ-Valerolactone | 21618-92-8 | >95.00% | |
An active metabolite of various polyphenols | ||||
| GC52245 | CAY10792 | 2361009-68-7 | >98.00% | |
An anticancer agent | ||||
| GC52269 | Cinnabarinic Acid-d4 | - | >99.00% | |
An internal standard for the quantification of cinnabarinic acid | ||||
| GC52288 | Fumonisin B1-13C34 | 1217458-62-2 | >95.00% | |
An internal standard for the quantification of fumonisin B 1 | ||||
| GC52293 | STAT3 Inhibitor 4m | - | >98.00% | |
A STAT3 inhibitor | ||||
| GC52318 | Oleic Acid-13C5 | 1255644-48-4 | >95.00% | |
An internal standard for the quantification of oleic acid | ||||
| GC52344 | Bak BH3 (72-87) (human) (trifluoroacetate salt) | - | >95.00% | |
A Bak-derived peptide | ||||
| GC52355 | BimS BH3 (51-76) (human) (trifluoroacetate salt) | - | >95.00% | |
A Bim-derived peptide | ||||
| GC52364 | Vimentin (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated vimentin peptide | ||||
| GC52367 | Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide | - | >99.00% | |
A biotinylated and citrullinated mutant vimentin peptide | ||||
| GC52370 | Citrullinated Vimentin (R144) (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated and citrullinated vimentin peptide | ||||
| GC52371 | Vimentin (G146R) (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated mutant vimentin peptide | ||||
| GC52372 | Ac-VDVAD-AFC (trifluoroacetate salt) | - | >95.00% | |
A fluorogenic substrate for caspase-2 | ||||
| GC52472 | Inostamycin A (sodium salt) | - | >85.00% | |
A bacterial metabolite with anticancer activity | ||||
| GC52476 | Bax Inhibitor Peptide V5 (trifluoroacetate salt) | - | >98.00% | |
A Bax inhibitor | ||||
| GC52485 | Ceramide (non-hydroxy) (bovine spinal cord) | - | >98.00% | |
A sphingolipid | ||||
| GC52486 | Ceramide Phosphoethanolamine (bovine) | - | >98.00% | |
A sphingolipid | ||||